Net Income

UK MSP Babble ditches fragmented tools for NinjaOne's unified platform, aiming to boost efficiency, scale operations, and meet strict public sector compliance.

The largest study of its kind reveals metabolic signatures that predict severe neurotoxicity in CAR T-cell patients, paving the way for safer treatments.

Xerox secures $450M by leveraging its iconic brand in a TPG joint venture, but is this a savvy move for its digital future or a costly financial fix?

Ditching passive holding, Lite Strategy generated $600k from Litecoin options to fund buybacks. Is this the new playbook for corporate crypto finance?

Orbia Netafim launches its Dosing 5G range, using self-learning AI to automate nutrient delivery, boost yields, and advance sustainable agriculture.

The American Diabetes Association is funding seven visionary scientists using AI, CRISPR, and stem cells to forge the next frontier in diabetes treatment.

The robotics firm unveils a new three-pillar strategy and strong finances, but faces class-action lawsuits over its rapid transformation and partnerships.

With new Series A funding, Daffodil Health's AI platform aims to dismantle the opaque, costly systems that drive up U.S. healthcare spending.

ETST announces a major restructuring with executive pay cuts and portfolio changes, projecting $1.4M in savings and positioning for institutional investment.

Transaction Network Services launches a self-service portal, giving firms direct control to combat the spiraling, multi-billion-dollar expense of market data.

With a steady monthly dividend and a 7.8% yield, Apple Hospitality REIT offers income for investors. But what does it say about the hotel industry's health?

A historic January saw 27 organ donors and 78 transplants, a milestone driven by community generosity and strategic excellence in Northeast Ohio.

A new report shows most audit leaders see AI fraud as a top risk, yet less than 40% feel equipped to fight it, exposing a critical corporate vulnerability.

Security giant Senstar finalizes its acquisition of 3D LiDAR innovator Blickfeld, a strategic move set to revolutionize security with smarter detection.

A defense firm is marketing a military-grade weapon system for school safety, igniting a fierce debate over security, ethics, and market motives.

First-ever bedrock drilling at Copeçal West validates a 6km surface anomaly, hinting at a large-scale gold deposit in a historically rich mining region.

As KP Tissue prepares to release Q4 2025 results, all eyes are on Kruger Products' performance after a year of major strategic investments and expansion.

As AI 'hallucinations' cost firms billions, one company claims a breakthrough with 99%+ factual accuracy. But can it bridge the AI trust gap?

A major patent deal shields Esperion's flagship drugs from generics, securing future revenue but delaying cheaper options for millions of patients.

A partnership between NSA Labs and Proscia is slashing study times for brain research, showing how digital platforms are key to finding new therapies faster.